Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Cited by
Items 901–1,000 of 1,013
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs
Altucci, L., Clarke, N., Nebbioso, A., Scognamiglio, A., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.019 · Cited by 64
Zorn, C. S., Wojno, K. J., McCabe, M. T., Kuefer, R., Gschwend, J. E., & Day, M. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2381 · Cited by 55
Immunologic and neurodevelopmental susceptibilities of autism
Pessah, I. N., Seegal, R. F., Lein, P. J., LaSalle, J., Yee, B. K., Van De Water, J., & Berman, R. F. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.006 · Cited by 51
“The importance of epigenetic mechanisms in regulating human brain development has been recently revealed by the discovery of the genetic bases of several human neurodevelopmental disorders (Egger et al., 2004; Hendrich and Bickmore, 2001; Zoghbi, 2003).”
BackgroundGlutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 62
Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome
Kirk, H., Cefalu, W. T., Ribnicky, D., Liu, Z., & Eilertsen, K. J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.03.006 · Cited by 54
Additive effect of zinc oxide nanoparticles and isoorientin on apoptosis in human hepatoma cell line
Li, Y., Wang, Y., Wang, J., Xiao, H., & Liu, X. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2013.12.015 · Cited by 52
Liu, D.-C., & Yang, Z. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.05.010 · Cited by 56
Structural Competency as a Framework for Training in Counseling Psychology
Ali, A., & Sichel, C. E. (2014) · The Counseling Psychologist · doi:10.1177/0011000014550320 · Cited by 55
Pulukuri, S. M. K., Gorantla, B., & Rao, J. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705867200 · Cited by 51
RetractedAntroquinonol D, Isolated from Antrodia camphorata , with DNA Demethylation and Anticancer Potential
Wang, S.-C., Lee, T., Hsu, C., Chang, Y., Chang, M.-S., Wang, Y., Ho, Y., Wen, W., & Lin, R.-K. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4056924 · Cited by 51
Zhao, W., Ma, N., Wang, S., Mo, Y., Zhang, Z., Huang, G., Midorikawa, K., Hiraku, Y., Oikawa, S., Murata, M., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0554-9 · Cited by 51
Parade, S. H., Novick, A. M., Parent, J. M., Seifer, R., Klaver, S. J., Marsit, C. J., Gobin, A. P., Yang, B., & Tyrka, A. R. (2017) · Development and Psychopathology · doi:10.1017/s0954579417001274 · Cited by 56
Epigenetics and microRNAs in cardiovascular diseases
Colpaert, R. M. W., & Calore, M. (2021) · Genomics · doi:10.1016/j.ygeno.2020.12.042 · Cited by 54
Hambach, L., Ling, K., Pool, J., Aghai, Z., Blokland, E. C., Tanke, H. J., BRUIJN, J. A., Halfwerk, H., van Boven, H., Wieles, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-158956 · Cited by 51
Targa, F. R., Rosa-Velázquez, I. A. D. L., Soto‐Reyes, E., & Benítez-Bribiesca, L. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00420.x · Cited by 54
Understanding α‐Globin Gene Regulation: Aiming to Improve the Management of Thalassemia
HIGGS, D. R., GARRICK, D., ANGUITA, E., DE GOBBI, M., HUGHES, J., MUERS, M., VERNIMMEN, D., LOWER, K., LAW, M., ARGENTARO, A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.012 · Cited by 48
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2
Scognamiglio, A., Nebbioso, A., Manzo, F., Valente, S., Mai, A., & Altucci, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.007 · Cited by 56
Desaulniers, D., Xiao, G.-H., Leingartner, K., Chu, I., Musicki, B., & Tsang, B. K. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi178 · Cited by 50
“Changes in DNA methylation can affect tissue differentiation, nervous system development, and intellectual disorders (Costa et al., 2004; Egger et al., 2004 ).”
BackgroundTahir, M. A. A., Norouzi, M., Khan, S. S., Davie, J., Yamanaka, S., & Ashraf, A. B. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109302 · Cited by 56
Bouhadana, D., Pagé, M.-H. G., Montjean, D., Bélanger, M., Benkhalifa, M., Miron, P., & Petrella, F. (2025) · Antioxidants · doi:10.3390/antiox14081013 · Cited by 59
Genome‐wide DNA methylation patterns in discordant sib pairs with alcohol dependence
Zhao, R., Zhang, R., Li, W., Liao, Y., Tang, J., Miao, Q., & Hao, W. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12010 · Cited by 51
Piyathilake, C. J., Macaluso, M., Alvarez, R. D., Chen, M., Badiga, S., Edberg, J. C., Partridge, E. E., & Johanning, G. L. (2010) · Cancer · doi:10.1002/cncr.25511 · Cited by 50
Lee, J. H., Shu, L., Fuentes, F., Su, Z., & Kong, A. T. (2013) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.107700 · Cited by 52
The potential role of DNA methylation in the pathogenesis of abdominal aortic aneurysm
Toghill, B. J., Saratzis, A. N., Harrison, S. C., Verissimo, A. R., Mallon, E. B., & Bown, M. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.001 · Cited by 52
The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma
Koshizuka, K., Hanazawa, T., Fukumoto, I., Kikkawa, N., Okamoto, Y., & Seki, N. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.105 · Cited by 56
Epigenetic small molecule modulators of histone and DNA methylation
Hauser, A., Robaa, D., & Jung, M. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.03.003 · Cited by 53
Li, Y., Pan, X., Roberts, M. L., Liu, P., Kotchen, T. A., Cowley, A. W., Mattson, D. L., Liu, Y., Liang, M., & Kidambi, S. (2018) · Epigenomics · doi:10.2217/epi-2018-0025 · Cited by 54
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
Zhang, R., Lai, L., He, J., Chen, C., You, D., Duan, W., Dong, X., Zhu, Y., Lin, L., Shen, S., et al. (2019) · Epigenetics · doi:10.1080/15592294.2019.1573066 · Cited by 53
Qian, Y., Changle, C., Jiang, L., Jing, Z., & Ren, Q. (2019) · BMC Genomics · doi:10.1186/s12864-019-5633-1 · Cited by 54
Aberrant DNA Methylation of ABC Transporters in Cancer
Zappe, K., & Cichna‐Markl, M. (2020) · Cells · doi:10.3390/cells9102281 · Cited by 64
Quantitative analysis of human tissue-specific differences in methylation
Igarashi, J., Muroi, S., Kawashima, H., Wang, X., Shinojima, Y., Kitamura, E., Oinuma, T., Nemoto, N., Song, F., Ghosh, S., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.044 · Cited by 53
Cai, X., & Wang, X. (2007) · IEEE Signal Processing Magazine · doi:10.1109/msp.2007.273051 · Cited by 56
Barangi, S., Hayes, A. W., Reiter, R. J., & Karimi, G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.010 · Cited by 49
Epigenetic regulation of bone remodeling and bone metastasis
Sharma, G., Sultana, A., Abdullah, K. M., Pothuraju, R., Nasser, M. W., Batra, S. K., & Siddiqui, J. A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.11.002 · Cited by 53
Chen, J., Fu, Z., Ji, C., Gu, P., Xu, P., Yu, N., Kan, Y., Wu, X., Shen, R., & Shen, Y. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.04.010 · Cited by 49
Corsetti, M. T., Salvi, F., Perticone, S., Baraldi, A., Paoli, L. D., Gatto, S., Pietrasanta, D., Pini, M., Primon, V., Zallio, F., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.02.021 · Cited by 53
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 60
Tsai, C. T., & So, C. W. E. (2016) · Oncogene · doi:10.1038/onc.2016.315 · Cited by 49
Yeh, C., Chang, L.-Y., Lin, S., Chou, J., Hsieh, H., Zeng, L.-H., Chuang, S.-Y., Wang, H.-W., Dittner, C., Lin, C.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31690 · Cited by 53
Epigenetic Changes in Neurodegenerative Diseases
Kwon, M. J., Kim, S., Han, M. H., & Lee, S. B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0233 · Cited by 47
Kuang, Y., Lu, F., Guo, J., Xu, H., Wang, Q., Xu, C., Zeng, L.-J., & Yi, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s134784 · Cited by 49
Mitsiogianni, M., Amery, T., Franco, R., Zoumpourlis, V., Pappa, A., & Panayiotidis, M. I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.001 · Cited by 52
Advancements in the Development of non‐BET Bromodomain Chemical Probes
Clegg, M. A., Tomkinson, N. C. O., Prinjha, R. K., & Humphreys, P. G. (2019) · ChemMedChem · doi:10.1002/cmdc.201800738 · Cited by 51
Circulating metabolite homeostasis achieved through mass action
Li, X., Hui, S., Mirek, E. T., Jonsson, W. O., Anthony, T. G., Lee, W. D., Zeng, X., Jang, C., & Rabinowitz, J. D. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00517-1 · Cited by 51
Reid, A. E., Hooker, J., Shumay, E., Logan, J., Shea, C., Kim, S. W., Collins, S., Xu, Y., Volkow, N., & Fowler, J. S. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.005 · Cited by 50
Epigenetic dysfunctional diseases and therapy for infection and inflammation
Samanta, S., Rajasingh, S., Cao, T., Dawn, B., & Rajasingh, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.030 · Cited by 54
Murat, K., Grüning, B. A., Poterlowicz, P. W., Westgate, G. E., Tobin, D. J., & Poterlowicz, K. (2020) · GigaScience · doi:10.1093/gigascience/giaa049 · Cited by 50
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy
Wei, H., Xiang, L., Wayne, A. S., Chertov, O., FitzGerald, D. J., Bera, T. K., & Pastan, I. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204523109 · Cited by 53
Elevated KIAA 0101 expression is a marker of recurrence in human gastric cancer
Zhu, K., Diao, D., Dang, C., Shi, L., Wang, J., Yan, R., Yuan, D., & Li, K. (2012) · Cancer Science · doi:10.1111/cas.12083 · Cited by 48
Hummel-Eisenbeiss, J., Hascher, A., Hals, P., Sandvold, M. L., Müller‐Tidow, C., Lyko, F., & Rius, M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.086801 · Cited by 48
Epigenetic mechanisms of plant-derived anticancer drugs
Schneider‐Stock, R., Ghantous, A., Bajbouj, K., Saikali, M., & Darwiche, N. (2011) · Frontiers in bioscience · doi:10.2741/3919 · Cited by 50
Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
Pal, J., Patil, V. S., Mondal, B., Shukla, S. K., Hegde, A. S., Arivazhagan, A., Santosh, V., & Somasundaram, K. (2016) · Genes & Cancer · doi:10.18632/genesandcancer.105 · Cited by 49
Epigenetics and vascular diseases
Stratton, M. S., Farina, F. M., & Elia, L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.010 · Cited by 51
Modifications épigénétiques et cancer
Deltour, S., Chopin, V., & Leprince, D. (2005) · médecine/sciences · doi:10.1051/medsci/2005214405 · Cited by 54
The regulation of neuronal gene expression by alcohol
Pignataro, L., Varodayan, F. P., Tannenholz, L., & Harrison, N. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.002 · Cited by 52
Multi-omics integration strategies for animal epigenetic studies — A review
Kim, D.-Y., & Kim, J.-M. (2021) · Animal Bioscience · doi:10.5713/ab.21.0042 · Cited by 47
“Epigenetics can be defined as the inheritable changes that modify DNA or related proteins without altering the DNA sequence [2].”
BackgroundEpigenetic regulation of inflammation in insulin resistance
Klimczak, S., & Śliwińska, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.004 · Cited by 48
Recent progress and structural analyses of domain‐selective BET inhibitors
Divakaran, A., Harki, D. A., & Pomerantz, W. C. K. (2023) · Medicinal Research Reviews · doi:10.1002/med.21942 · Cited by 48
Epigenetic reprogramming as a key contributor to melanocyte malignant transformation
Molognoni, F., da Cruz, A. T., Meliso, F. M., Morais, A. S., de Souza, C. F., Xander, P. B., Bischof, J. M., Costa, F. F., Soares, M. B., Liang, G., et al. (2011) · Epigenetics · doi:10.4161/epi.6.4.14917 · Cited by 50
Self-citationEpigenetic Therapy for Breast Cancer
Cai, F., Kohler, C., Zhang, B., Wang, M., Chen, W., & Zhong, X. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074465 · Cited by 47
Wagner, A. E., Piegholdt, S., Ferraro, M., Pallauf, K., & Rimbach, G. H. (2015) · Food & Function · doi:10.1039/c4fo01119h · Cited by 48
Epigenetic modifications in human thyroid cancer
Faam, B., Ghaffari, M. A., Ghadiri, A., & Azizi, F. (2014) · Biomedical Reports · doi:10.3892/br.2014.375 · Cited by 50
Linking Chromatin Fibers to Gene Folding by Hierarchical Looping
Bascom, G. D., & Schlick, T. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.01.003 · Cited by 52
Wen, S., Wang, J., Liu, P., Li, Y., Lu, W., Hu, Y., Liu, J., He, Z., & Huang, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.015 · Cited by 48
Li, C., Shen, Z., Bavarian, R., Yang, F., & Bhattacharya, A. (2017) · Dental Clinics of North America · doi:10.1016/j.cden.2017.08.002 · Cited by 48
Tao, X., Zuo, Q., Ruan, H., Wang, H., Jin, H., Cheng, Z., Lv, Y., Qin, W., & Wang, C. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz005 · Cited by 50
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
Aghamir, S. M. K., Heshmat, R., Ebrahimi, M., & Khatami, F. (2020) · Epigenetics Insights · doi:10.1177/2516865720904052 · Cited by 48
Epigenetics: New Insights into Mammary Gland Biology
Ivanova, E., Guillou, S. L., Hue‐Beauvais, C., & Provost, F. L. (2021) · Genes · doi:10.3390/genes12020231 · Cited by 54
Sato, K., Kumar, A., Hamada, K., Okada, C., Oguni, A., Machiyama, A., Sakuraba, S., Nishizawa, T., Nureki, O., Kono, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26913-5 · Cited by 50
Insights into roles of METTL14 in tumors
Liu, X., Du, Y., Huang, Z., Qin, H., Chen, J., & Zhao, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.13168 · Cited by 49
Dudley, K. J., Revill, K., Whitby, P., Clayton, R. N., & Farrell, W. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0234 · Cited by 51
Epigenomic profiling of cancer cells
Gargiulo, G., & Minucci, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.021 · Cited by 50
Hsi, L. C., Xi, X., Wu, Y., & Lippman, S. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0218 · Cited by 47
Epigenetic Regulation and Colorectal Cancer
Matsubara, N. (2011) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e318233a1ef · Cited by 49
The pituitary tumour epigenome: aberrations and prospects for targeted therapy
Yacqub‐Usman, K., Richardson, A., Duong, C. V., Clayton, R. N., & Farrell, W. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.54 · Cited by 50
Hydroxymethylation as a Novel Environmental Biosensor
Dao, T., Cheng, R. Y. S., Revelo, M. P., Mitzner, W., & Tang, W. (2014) · Current Environmental Health Reports · doi:10.1007/s40572-013-0005-5 · Cited by 51
Chen, L. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i43.5718 · Cited by 46
Yan, C., Xiu, Z., Li, X., Li, S., Hao, C., & Teng, H. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22047 · Cited by 48
Zhi, H., Ning, S., Li, X., Li, Y., Wu, W., & Li, X. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku575 · Cited by 47
Kojima, A., Kobayashi, T., Ito, S., Murasawa, A., Nakazono, K., & Yoshie, H. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12314 · Cited by 49
Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer
Zhang, C., Wang, S., Liu, Y., & Yang, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10767 · Cited by 49
Modified nucleoside triphosphates exist in mammals
Jiang, H.-P., Xiong, J., Liu, F.-L., Ma, C.-J., Tang, X.-L., Yuan, B., & Feng, Y.-Q. (2018) · Chemical Science · doi:10.1039/c7sc05472f · Cited by 46
Bhattacharjee, R., Moriam, S., Umer, M., Nguyen, N., & Shiddiky, M. J. A. (2018) · The Analyst · doi:10.1039/c8an01348a · Cited by 53
Polli, A., Ickmans, K., Godderis, L., & Nijs, J. (2018) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2018.09.118 · Cited by 48
LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
Xie, Q., Tang, T., Pang, J., Xu, J., Yang, X., Wang, L.-A., Huang, Y., Huang, Z., Liu, G., Tong, D., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01234 · Cited by 46
Physical modeling of the heritability and maintenance of epigenetic modifications
Sandholtz, S. H., MacPherson, Q., & Spakowitz, A. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920499117 · Cited by 49
Epigenetic principles underlying epileptogenesis and epilepsy syndromes
Conboy, K., Henshall, D. C., & Brennan, G. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105179 · Cited by 47
Weiss, F. D., Calderón, L., Wang, Y.-F., Georgieva, R., Guo, Y., Cvetešić, N., Kaur, M., Dharmalingam, G., Krantz, I. D., Lenhard, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23141-9 · Cited by 49
Kim, S., Lee, K., Jang, H.-R., Kim, J.-H., Noh, S., Song, K., Cho, J.-S., Jeong, H. Y., Kim, S., Yoo, H., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0142 · Cited by 46
Zhang, P., Su, Y., & Lu, Q. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04261.x · Cited by 50
Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
Leone, G. G. M., D’Alò, F., Zardo, G., Voso, M. T., & Nervi, C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784534947 · Cited by 56
Microglia lactylation in relation to central nervous system diseases
Yang, H., Mo, N., Tong, L., Dong, J., Fan, Z., Jia, M., Yue, J., & Wang, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-00805 · Cited by 52
Li, L., Su, X., Choi, G. C. G., Cao, Y., Ambinder, R. F., & Tao, Q. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-125 · Cited by 47
Rathert, P., Dhayalan, A., Ma, H., & Jeltsch, A. (2008) · Molecular BioSystems · doi:10.1039/b811673c · Cited by 48
Wee, E. J. H., Thu Ha, N. G. O., & Trau, M. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0100-6 · Cited by 46
Kochmanski, J. J., Marchlewicz, E. H., Savidge, M., Montrose, L. B., Faulk, C. D., & Dolinoy, D. C. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.07.021 · Cited by 48
Cheng, J. R., Song, J., He, X., Zhang, M., Hu, S., Zhang, S., Yu, Q., Yang, P. C., Xiong, F., Wang, D. W., et al. (2016) · Diabetes · doi:10.2337/db16-0151 · Cited by 48
Regulation of microRNA-1 (miR-1) expression in human cancer
Han, C., Shen, J. K., Hornicek, F. J., Kan, Q., & Duan, Z. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.12.004 · Cited by 46
Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer
Liu, S., Chen, X., Chen, R., Wang, J., Zhu, G., Jiang, J., Wang, H., Duan, S., & Huang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16754 · Cited by 48
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.